Literature DB >> 23592856

Implications of Trichomonas vaginalis nucleic acid amplification testing on medical training and practice.

Lisa V Smith, Frank Sorvillo, Tony Kuo.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23592856      PMCID: PMC3647919          DOI: 10.1128/JCM.00188-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

Review 2.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

3.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

4.  Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.

Authors:  Kwame Owusu-Edusei; Mehul N Tejani; Thomas L Gift; Charlotte K Kent; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

5.  Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Authors:  Hillard Weinstock; Stuart Berman; Willard Cates
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.